Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01749189 · ClinicalTrials.gov registry record · NA
Effect of Protein Blend Supplementation During Exercise Training on Muscle Growth and Strength
A NA study, sponsored by DuPont Nutrition and Health.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT01749189: Completed NA study, sponsored by DuPont Nutrition and Health.
NCT01749189 is a NA study that has completed, run by DuPont Nutrition and Health. The registered enrollment target is 58 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01749189, a NA study, has completed, sponsored by DuPont Nutrition and Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
This study will investigate the effects of a soy/dairy protein blend on muscle growth and strength. In sports nutrition and in aging it is important to have healthy muscles. This can be achieved with exercise and nutrition. Consumption of protein following resistance exercise can promote healthy muscle growth and help improve strength. Young healthy men will be studied during a 12 week resistance exercise training program and be given protein supplements every day during the study. The hypothesis is that a blend of soy, whey and casein will induce a greater muscle gain and strength increase than the control.
Primary Outcome
Muscle Mass will be determined by DEXA
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Whey
- DIETARY_SUPPLEMENT Blend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-06 |
| Phase | NA |
What the finished NCT01749189 record still lists
NCT01749189 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01749189 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01749189 about?
NCT01749189 is a clinical study titled "Effect of Protein Blend Supplementation During Exercise Training on Muscle Growth and Strength". This study will investigate the effects of a soy/dairy protein blend on muscle growth and strength. In sports nutrition and in aging it is important to have healthy muscles. This can be achieved with exercise and nutrition. Consumption of protein following resistance exercise can promote healthy mus...
What is the current status of trial NCT01749189?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2012-07. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01749189?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Whey (DIETARY_SUPPLEMENT), Blend (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01749189?
This trial is sponsored by DuPont Nutrition and Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01749189's enrollment target sits among peer trials
58 1256th of 2000 higher than 740 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia